SNSE/GILDCL (SNSE/GILDCL)

Santiago Stock Exchange: SNSE/GILDCL · CLP

CLP 157,780

+7490.00 (+5.0%)· Recorded snapshot

Market cap	193.7T
Revenue (ttm)	28.1T
Net income (ttm)	-3T
EPS (ttm)	-CLP 2,578
P/E (forward)	18.7x
Dividend	CLP 2,994 (1.90%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 28.1T
Net income (ttm): -3T
EPS (ttm): -CLP 2,578
P/E (forward): 18.7x
Market cap: 193.7T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-20.7

P25 n/aP50 n/aP75 n/a

ROIC34.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/GILDCL indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-29
Employees	17,000
Employees change	-600
Employees growth	-3.41%
Enterprise value	CLP 214.6T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-24
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US3755581036
Last refreshed	2026-10-28
Market cap	CLP 193.7T
Next earnings date	2026-10-29
Price	CLP 157,780.00
Price currency	CLP
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/GILDCL
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	75.16x
Average P/E ratio (3Y)	133.64x
Average P/E ratio (5Y)	84.97x
Earnings yield	-1.63%
EV/EBIT	18.46x
EV/EBITDA	14.8x
EV/FCF	18x
EV/Sales	7.18x
FCF / EV yield	5.56%
FCF yield	6.16%
Forward P/E	18.73x
P/(FCF - SBC) ratio	17.47x
P/(OCF - SBC) ratio	16.63x
P/B ratio	17.9x
P/FCF ratio	16.25x
P/OCF ratio	15.52x
P/S ratio	6.9x
Price/EBITDA ratio	14.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.88%
EBITDA margin	47.94%
FCF margin	39.71%
Gross margin	79.6%
Operating margin	38.88%
Pretax margin	-6.42%
Profit margin	-10.64%
Profit per employee	CLP -175.6M
Profitable years	19
Revenue per employee	CLP 1.7B
ROA	14.09%
ROA (5Y)	10.85%
ROCE	30.88%
ROE	-20.68%
ROE (5Y)	24.33%
ROIC	34.37%
ROIC (5Y)	21.93%
SBC / revenue	2.98%
Tax / revenue	4.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	38.15%
FCF growth (Q)	376.81%
FCF growth (QoQ)	41.45%
FCF growth 3Y	13.19%
FCF growth 5Y	8.85%
Gross profit growth	6.96%
Gross profit growth (Q)	11.52%
Gross profit growth 3Y	3.69%
Gross profit growth 5Y	1.75%
Net income growth years	1
OCF growth	37.33%
OCF growth (Q)	332.04%
OCF growth (QoQ)	40.45%
OCF growth 10Y	-2.84%
OCF growth 3Y	12.52%
OCF growth 5Y	8.31%
Operating income growth	7.34%
Operating income growth (Q)	-5.23%
Operating income growth 3Y	6.62%
Operating income growth 5Y	-1.1%
Revenue growth	5.52%
Revenue growth (Q)	10.18%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	-0.61%
Revenue growth 3Y	3.61%
Revenue growth 5Y	2.72%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -561.1B
Depreciation and amortization	CLP 2.7T
EBIT	CLP 10.9T
EBITDA	CLP 13.5T
EPS	CLP -2,578.48
Financing cash flow	CLP -4.3T
Free cash flow	CLP 11.9T
Free cash flow minus SBC	CLP 11.1T
Gross profit	CLP 22.3T
Income taxes	CLP 1.2T
Investing cash flow	CLP -10T
Net borrowing	CLP 1.3T
Net cash flow	CLP -1.8T
Net income	CLP -3T
Operating cash flow minus SBC	CLP 11.6T
Operating income	CLP 10.9T
Revenue	CLP 28.1T
Stock-based compensation	CLP 837.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	CLP 8,781.67
Debt / EBITDA	1.78
Debt / equity	2.23
Debt / FCF	2.03
Goodwill	CLP 8.2T
Interest coverage	11.86
Long-term assets	CLP 31.7T
Long-term liabilities	CLP 23.8T
Net cash (debt)	CLP -19.7T
Net cash / market cap	-10.16%
Net debt / EBITDA	1.46
Net debt / equity	1.82
Net debt / FCF	1.65
Piotroski F-Score	5
Property, plant and equipment	CLP 5.8T
Shareholders' equity	CLP 10.8T
Tangible book value	CLP -9.7T
Tangible book value per share	CLP -7,807.66
Total assets	CLP 45.5T
Total cash	CLP 4.5T
Total debt	CLP 24.2T
Total liabilities	CLP 34.7T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	CLP 13.8T
Current liabilities	CLP 10.9T
Current ratio	1.27
Inventory turnover	3.29
Net working capital	CLP 421B
Quick ratio	0.9
Working capital	CLP 2.7T
Working capital turnover	8,695.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.39%
Dividend growth	0.49%
Dividend growth (3Y)	6.11%
Dividend growth (5Y)	7.55%
Dividend growth years	2
Dividend payment date	2026-09-29
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	CLP 2,993.63
Dividend yield	1.9%
Ex-dividend date	2026-09-15
Last dividend	CLP 785.93
Shareholder yield	3.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 131,567.47
1D price change	4.98%
1M price change	4.86%
1M total return	4.86%
1W price change	3.59%
1W total return	3.59%
1Y price change	90.24%
1Y return CAGR	95.45%
1Y total return	95.36%
20-day SMA	CLP 145,990.00
200-day SMA	CLP 125,668.35
3M price change	20.93%
3M total return	21.63%
50-day SMA	CLP 139,038.20
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 157,780.00
52-week high date	2026-10-26
52-week low	CLP 79,000.00
52-week low date	2026-02-06
6M price change	16.55%
6M total return	17.9%
All-time high	CLP 150,290.00
All-time high date	2026-10-20
All-time low	CLP 72,660.00
All-time low date	2024-07-25
Average true range (ATR)	CLP 814.52
Average volume	0
Change from 52-week high	0%
Change from 52-week low	99.72%
Change from all-time high	0%
Change from all-time low	106.84%
Monthly RSI	92.13
Previous close	CLP 150,290.00
Price vs 150-day SMA	14.23%
Price vs 20-day SMA	2.95%
Price vs 200-day SMA	19.59%
Price vs 50-day SMA	8.09%
RSI	78.31
Sharpe ratio	1.22
Sortino ratio	14.01
Weekly RSI	77.84
YTD price change	90.24%
YTD total return	93.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.88%
Shares change (YoY)	-1.39%
Shares held by insiders	0.09%
Shares held by institutions	90.91%
Short ratio	3.3 days

Deeper analysis on SNSE/GILDCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/GILDCL report

Is a complete SNSE/GILDCL research report available?

No complete published report is available for snse/GILDCL (SNSE/GILDCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/GILDCL (SNSE/GILDCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/GILDCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/GILDCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/GILDCL

Frequently asked questions